Matches in DBpedia 2014 for { <http://dbpedia.org/resource/Dendreon> ?p ?o. }
Showing items 1 to 63 of
63
with 100 items per page.
- Dendreon abstract "Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer. It consists of a mixture of the patient's own blood cells (autologous, with dendritic cells thought to be the most important) that have been incubated with the Dendreon PAP-GM-CSF fusion protein.Phase III clinical trial results demonstrating a survival benefit for prostate cancer patients receiving the drug were presented at the AUA meeting on April 28, 2009. After going through the approval process, Provenge was given full approval by the FDA on April 29, 2010. Dendreon's stock value fell 66% on August 4, 2011 after abandoning its forecast for its debut drug Provenge.".
- Dendreon industry Biomedicine.
- Dendreon locationCity Seattle.
- Dendreon numberOfEmployees "1497".
- Dendreon product Sipuleucel-T.
- Dendreon service Sipuleucel-T.
- Dendreon type Public_company.
- Dendreon wikiPageExternalLink www.dendreon.com.
- Dendreon wikiPageExternalLink ucm210012.htm.
- Dendreon wikiPageExternalLink www.provenge.com.
- Dendreon wikiPageID "26400298".
- Dendreon wikiPageRevisionID "604153646".
- Dendreon caption "Targeting Cancer, Transforming Lives".
- Dendreon hasPhotoCollection Dendreon.
- Dendreon homepage www.dendreon.com.
- Dendreon industry Biomedicine.
- Dendreon locationCity Seattle.
- Dendreon locationCountry "US".
- Dendreon logo File:Dendreon_logo.png.
- Dendreon name "Dendreon".
- Dendreon numEmployees "1497".
- Dendreon products "Provenge".
- Dendreon services "Provenge".
- Dendreon type Public_company.
- Dendreon wordnet_type synset-company-noun-1.
- Dendreon subject Category:Biotechnology_companies_of_the_United_States.
- Dendreon subject Category:Companies_based_in_Seattle,_Washington.
- Dendreon subject Category:Companies_in_the_NASDAQ_Biotechnology_Index.
- Dendreon subject Category:Companies_listed_on_NASDAQ.
- Dendreon point "47.607948 -122.338547".
- Dendreon type Abstraction100002137.
- Dendreon type BiotechnologyCompaniesOfTheUnitedStates.
- Dendreon type CompaniesBasedInSeattle,Washington.
- Dendreon type CompaniesInTheNASDAQBiotechnologyIndex.
- Dendreon type Company108058098.
- Dendreon type Group100031264.
- Dendreon type Institution108053576.
- Dendreon type Organization108008335.
- Dendreon type SocialGroup107950920.
- Dendreon type YagoLegalActor.
- Dendreon type YagoLegalActorGeo.
- Dendreon type YagoPermanentlyLocatedEntity.
- Dendreon type Agent.
- Dendreon type Company.
- Dendreon type Organisation.
- Dendreon type Organization.
- Dendreon type Business.
- Dendreon type Agent.
- Dendreon type SocialPerson.
- Dendreon type Thing.
- Dendreon type SpatialThing.
- Dendreon comment "Dendreon (NASDAQ: DNDN) is a Seattle based biotechnology company. Its lead product, Provenge (known generically as sipuleucel-T), is an immunotherapy for prostate cancer.".
- Dendreon label "Dendreon".
- Dendreon sameAs m.0kqkf3.
- Dendreon sameAs Q5256667.
- Dendreon sameAs Q5256667.
- Dendreon sameAs Dendreon.
- Dendreon lat "47.607948".
- Dendreon long "-122.338547".
- Dendreon wasDerivedFrom Dendreon?oldid=604153646.
- Dendreon homepage www.dendreon.com.
- Dendreon isPrimaryTopicOf Dendreon.
- Dendreon name "Dendreon".